Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_69ece09bafee7e0c49d1f7951a3faa2c |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-11 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-21 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-76 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-106 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-1135 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-177 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-6849 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 |
filingDate |
2007-09-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2011-08-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cc7cbc04f4c24317f40abf29f8d656e8 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7053b3ba278bae57fa4d34666f48ce5e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_150635570b49e346f45eefd094695546 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fb74d486d80219bdc462fae9be50b00c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2004facd703fcd8f5d7f9bb661df72c4 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2ee4900c32d2ffff6fb53e02d260ead4 |
publicationDate |
2011-08-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
EP-2061906-B1 |
titleOfInvention |
Methods and compositions for the diagnosis and treatment of lung cancer using pdgfra, kit or kdr gene as genetic marker |
abstract |
Methods and compositions are provided for the diagnosis and treatment of lung cancers in particular NSCLC associated with amplification or overexpression of the PRO gene, i.e. any of PDGFRA, KIT or KDR. |
priorityDate |
2006-09-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |